• Issue

    Experimental Dermatology: Volume 33, Issue 8

    August 2024

COVER IMAGE

Free Access

Cover Image

  • First Published: 07 May 2025
Cover Image Volume 33 Issue 8, 2024

The cover image is based on the article An overview of S100 proteins and their functions in skin homeostasis, interface dermatitis conditions and other skin pathologies by Jillian Richmond et al., https://doi.org/10.1111/exd.15158.

ISSUE INFORMATION

Free Access

Issue Information

  • First Published: 29 July 2024

RESEARCH ARTICLE

REVIEW ARTICLE

Free Access

Histone modification in psoriasis: Molecular mechanisms and potential therapeutic targets

  • First Published: 01 August 2024

This paper reviewed the regulatory mechanisms and biological effects of histone modifications and their roles in the pathogenesis of psoriasis. It highlights the role of epigenetic inheritance and the potential of targeting histone modification as an alternative therapeutic approach for psoriasis and other-related diseases.

RESEARCH ARTICLE

Sulfuric acid-induced skin neoplasms in immunocompetent mice

  • First Published: 12 August 2024
Sulfuric acid-induced skin neoplasms in immunocompetent mice

This groundbreaking study highlights the potential for skin irritation and oxidative stress induced by chronic exposure to sulfuric acid (SA) in Swiss albino mice. In addition, it elucidates the ability of SA to promote neoplastic proliferation characterized by significant expressions of Ki-67 and p53 markers.

Open Access

Genetic polymorphisms to identify patients with an optimal response to tildrakizumab in psoriasis patients from real-life clinical practice

  • First Published: 30 July 2024
Genetic polymorphisms to identify patients with an optimal response to tildrakizumab in psoriasis patients from real-life clinical practice

One hundred eighty polymorphisms were analysed in 90 patients with plaque psoriasis treated with tildrakizumab in routine clinical practice. The combination of four polymorphisms in TNFAIP3, ATG5 PDE4D and IL17RC genes, along with weight (>76 kg) and disease duration (>27 years), showed a sensitivity of 88.5% and specificity of 83.3% to discriminate responders (PASI ≤1) and non-responders (PASI >1) at 12 months.